1. Home
  2. SVRA vs KELYA Comparison

SVRA vs KELYA Comparison

Compare SVRA & KELYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVRA
  • KELYA
  • Stock Information
  • Founded
  • SVRA N/A
  • KELYA 1946
  • Country
  • SVRA United States
  • KELYA United States
  • Employees
  • SVRA N/A
  • KELYA N/A
  • Industry
  • SVRA Biotechnology: Pharmaceutical Preparations
  • KELYA Professional Services
  • Sector
  • SVRA Health Care
  • KELYA Consumer Discretionary
  • Exchange
  • SVRA Nasdaq
  • KELYA Nasdaq
  • Market Cap
  • SVRA 739.1M
  • KELYA 752.3M
  • IPO Year
  • SVRA N/A
  • KELYA N/A
  • Fundamental
  • Price
  • SVRA $3.82
  • KELYA $20.60
  • Analyst Decision
  • SVRA Strong Buy
  • KELYA Buy
  • Analyst Count
  • SVRA 5
  • KELYA 1
  • Target Price
  • SVRA $12.00
  • KELYA $29.00
  • AVG Volume (30 Days)
  • SVRA 1.3M
  • KELYA 231.4K
  • Earning Date
  • SVRA 11-07-2024
  • KELYA 11-07-2024
  • Dividend Yield
  • SVRA N/A
  • KELYA 1.45%
  • EPS Growth
  • SVRA N/A
  • KELYA 5360.05
  • EPS
  • SVRA N/A
  • KELYA 1.32
  • Revenue
  • SVRA N/A
  • KELYA $4,452,800,000.00
  • Revenue This Year
  • SVRA N/A
  • KELYA N/A
  • Revenue Next Year
  • SVRA N/A
  • KELYA $8.90
  • P/E Ratio
  • SVRA N/A
  • KELYA $15.64
  • Revenue Growth
  • SVRA N/A
  • KELYA N/A
  • 52 Week Low
  • SVRA $3.12
  • KELYA $17.40
  • 52 Week High
  • SVRA $5.70
  • KELYA $25.27
  • Technical
  • Relative Strength Index (RSI)
  • SVRA 35.17
  • KELYA 44.43
  • Support Level
  • SVRA $3.77
  • KELYA $20.58
  • Resistance Level
  • SVRA $4.33
  • KELYA $21.38
  • Average True Range (ATR)
  • SVRA 0.22
  • KELYA 0.53
  • MACD
  • SVRA -0.07
  • KELYA -0.04
  • Stochastic Oscillator
  • SVRA 9.28
  • KELYA 4.67

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

About KELYA Kelly Services Inc.

Kelly Services Inc is a provider of workforce solutions and consulting and staffing services. The company's operations are divided into five business segments namely Professional & Industrial, Science, Engineering & Technology, Education, Outsourcing & Consulting, and International. Other than OCG, each segment delivers talent through staffing services, permanent placement, or outcome-based services. OCG segment delivers talent solutions including managed service providers, payroll process outsourcing, recruitment process outsourcing, and talent advisory services. International also delivers RPO talent solutions within its local markets. The majority of revenue is derived from Professional & Industrial.

Share on Social Networks: